BioSpace News Archive

Arbor Biotechnologies today announced the appointment of Steven J. Favaloro as Chief Financial Officer.

Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced its intention to appoint Timothy Scannell to its board of directors as an independent non-executive director.

Novan, Inc., announced its financial and operating results for the year ended December 31, 2021 and provided a corporate update.

Athira Pharma, Inc. today announced that preclinical data for the active metabolite of fosgonimeton and Athira’s new oral small molecule, ATH-1020, will be presented in two oral presentations at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting, taking place virtually, Feb. 28 - March 3, 2022.

Karyopharm Therapeutics Inc. announced changes to its clinical leadership team, including the appointment of Patricia Judson, M.D., as Senior Vice President of Medical Strategy and Stuart Poulton as Senior Vice President of Strategy and Portfolio Management.

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on March 1, 2022 at 8:30 a.m. ET to discuss fourth quarter and full year 2021 results and provide a general business update.

Cosette Pharmaceuticals, Inc., a New Jersey-based pharmaceutical company, today announced the launch of Prochlorperazine Edisylate injection, 10 mg/2ml (5mg/ml).

dievini Hopp BioTech holding GmbH & Co. KG (dievini), DH-LT-Investments GmbH and Dietmar Hopp today announced that they no longer plan to sell some of the CureVac common shares (NASDAQ: CVAC) to the public, as reported in a 13-D filing with the U.S. Securities and Exchange Commission (SEC) on 13 January 2022.

Otonomy, Inc. today announced the completion of patient enrollment in the Phase 2 clinical trial of OTO-313 in tinnitus.

Statera Biopharma, Inc. today announced unaudited, preliminary revenue and other financial results for its Fiscal Year ended December 31, 2021.